University of Montana

ScholarWorks at University of Montana
Biological Sciences Faculty Publications

Biological Sciences

3-2001

Experimental Model of Human Body Louse Infection Using Green
Fluorescent Protein-Expressing Bartonella Quintana
Pierre-Edouard Fournier
Michael F. Minnick
University of Montana - Missoula, mike.minnick@mso.umt.edu

Hubert Lepidi
Eric Salvo
Didier Raoult

Follow this and additional works at: https://scholarworks.umt.edu/biosci_pubs
Part of the Biology Commons

Let us know how access to this document benefits you.
Recommended Citation
Fournier, Pierre-Edouard; Minnick, Michael F.; Lepidi, Hubert; Salvo, Eric; and Raoult, Didier, "Experimental
Model of Human Body Louse Infection Using Green Fluorescent Protein-Expressing Bartonella Quintana"
(2001). Biological Sciences Faculty Publications. 141.
https://scholarworks.umt.edu/biosci_pubs/141

This Article is brought to you for free and open access by the Biological Sciences at ScholarWorks at University of
Montana. It has been accepted for inclusion in Biological Sciences Faculty Publications by an authorized
administrator of ScholarWorks at University of Montana. For more information, please contact
scholarworks@mso.umt.edu.

INFECTION AND IMMUNITY, Mar. 2001, p. 1876–1879
0019-9567/01/$04.00⫹0 DOI: 10.1128/IAI.69.3.1876–1879.2001
Copyright © 2001, American Society for Microbiology. All Rights Reserved.

Vol. 69, No. 3

NOTES
Experimental Model of Human Body Louse Infection Using
Green Fluorescent Protein-Expressing Bartonella quintana
PIERRE-EDOUARD FOURNIER,1 MICHAEL F. MINNICK,2 HUBERT LEPIDI,1,3
ERIC SALVO,1 AND DIDIER RAOULT1*

Received 7 August 2000/Accepted 18 October 2000

A laboratory colony of human body lice was experimentally infected by feeding on rabbits made artificially
bacteremic with a green fluorescent protein-expressing Bartonella quintana. B. quintana was detected in the gut
and feces until death but not in the eggs. The life span of the lice was not modified. The rabbit model should
provide valuable clues to the role of lice in the transmission of B. quintana.
Bartonella quintana is a fastidious gram-negative bacterium
that is regarded as a reemerging human pathogen (1) and is
responsible for various human diseases (12). Although trench
fever, the first clinical manifestation of B. quintana infection
to be recognized (13), affected thousands of soldiers during
World Wars I and II, medical interest in trench fever waned for
almost 30 years because the disease was only rarely encountered. In the 1990s, B. quintana was identified as an agent of
bacillary angiomatosis in AIDS patients (17), endocarditis (5,
16, 18), chronic bacteremia (3, 19), and chronic lymphadenopathy (15). These diseases are associated with homelessness or
cramped, unhygienic circumstances, together with cold weather and the presence of body lice. The role of lice had been
observed as early as 1920 (4). Various experiments have demonstrated that the disease could be induced in human volunteers (20) and Macacus rhesus monkeys (14) by injection of
B. quintana and that the bacterium multiplied in the gut lumen
of naturally (21) or intrarectally (8) infected lice without interfering with viability and was excreted in their feces (4, 8).
However, despite growing interest in louse-transmitted diseases, there is no currently available experimental model to
describe the relationship between B. quintana and the louse.
GFP-expressing B. quintana. B. quintana strain Oklahoma
(ATCC 49793) was obtained from the American Type Culture
Collection (Rockville, Md.) and cultivated as previously described (10). Plasmid pJMBGFP, containing the B. bacilliformis flagellin promoter and a Rep origin of replication obtained
from pBBR1-MCS2 (9) (Table 1), was provided by James M.
Battisti (Division of Biological Sciences, University Montana,
Missoula, Mont.). It was extracted and purified from Escherichia coli using a Midi Prep kit (Qiagen, Inc., Chatsworth,
Calif.) and then adjusted to 0.5 g/ml. Transformation proce-

dures were as previously described (6). The transformed bacteria were cultivated on 5% sheep blood agar containing 25 g
of kanamycin sulfate per ml and were further verified as B.
quintana by PCR amplification of the 16S-23S rDNA intergenic spacer (its) followed by sequencing (6). The presence of
plasmid DNA was checked as previously described (6).
Optimal transformation efficiencies were obtained at 6 ms
for a field strength of 12.5 kV/cm and a plasmid DNA amount
of 60 to 80 ng but were low, ranging from 3 ⫻ 10⫺5 to 7 ⫻ 10⫺5.
Colonies of green fluorescent protein (GFP)-expressing B. quintana began to appear at aproximately 12 to 16 days following
electroporation, which represents a growth lag time of approximately 8 to 12 days compared with the growth of untransformed bacteria on plate-to-plate passage. The colonies were
typically smaller than those formed by untransformed B. quintana at the same stage of growth. When the colonies were
subcultured on selective media, GFP expression was conserved
after 15 passages, suggesting that plasmid maintenance was
stable in the presence of antibiotic, but was lost after 5 passages in the absence of antibiotic. No growth was obtained on
selective media with wild-type B. quintana prepared under the
same conditions or B. quintana electroporated without DNA.
Sequencing of PCR-products amplified from the its revealed
100% identity to known sequences of B. quintana, confirming
that the transformants were B. quintana.
Experimental body louse infection. Body lice (Pediculus humanus corporis, strain Orlando) were kindly provided by D.
Richard-Lenoble (Laboratoire de Parasitologie, Faculté de
Médecine, Tours, France). A colony of lice was established and
nourished daily on the shaved abdomen of specific-pathogenfree (SPF) New Zealand White rabbits (Fig. 1a). The lice were
shown to be free from B. quintana by periodic its PCR amplification of samples from their gut and feces. One SPF rabbit,
designated R1, was first injected intravenously with 2.5 ml of a
solution of 10 mg of kanamycin (Sigma, St. Louis, Mo.) per ml,
and 15 min later was injected with 20 ml of a suspension of 106
CFU of pJMBGFP-expressing B. quintana per ml in saline,
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TABLE 1. Strains and plasmids used in this study
Strain or plasmid

Strains
E. coli DH5
B. quintana
Plasmids
pBBR1-MCS2
pFPV25
PJMBGFP

Genotype or relevant characteristics

Reference or source

F⫺ (⌽80dlacZ⌬M15) ⌬(lacZY AargF)U169 deoR recA1 endA1 hsdR17 (rK⫺ mK⫹), supE44
-thi-1 gyrA96 relA1 -CH616
‘Oklahoma’

Gibco-BRL (7)

Kmr Mob Rep origin, Bartonella shuttle vector
Source of promoterless GFP (gfpmut3a)
PBBR1-MCS2 with a 970-bp HindIII fragment containing B. bacilliformis flagellin promoter
(fla-pro) upstream of gfpmut3a

Michael Kovach (7)
Raphael Valdivia
James M. Battitsti (2)

day with 2.5 ml of 10 mg of kanamycin sulfate (Sigma) per ml.
To detect B. quintana, its amplification by PCR and culture on
kanamycin-containing agar for up to 60 days at 37°C under a
5% CO2 atmosphere were performed on blood drawn from the
infected rabbit after the lice had fed then every day for 5 days,
and then once a week for 2 months. Similar tests were per-

FIG. 1. Experimental model of body louse infection by GFP-expressing B. quintana. (a) Pediculus humanus humanus feeding on a rabbit; (b)
fluorescent colony isolated on selective agar from an infected louse 10 days after the initial infection; (c) autofluorescence of body lice; (d)
immunohistological detection of B. quintana. Note the numerous erythrocytes and the clusters of bartonellae in the intestine lumen (red clumps)
and against the intestine wall (blue). Streptavidin-biotin-peroxidase method, polyclonal rabbit anti-B. quintana used at a dilution of 1:400, hemalun
counterstain. Magnification, ⫻660.
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before 800 15-day-old lice, half of which were female, were
allowed to feed on its abdomen. The lice were then kept at
30°C and 70% humidity. The day of infection was referred to
as day 1. On the following days, lice were allowed to feed daily
on a second SPF rabbit designated R2. Before the lice were
allowed to feed each day, R2 was injected intravenously each
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formed on 15 lice harvested after feeding on the infected
rabbit, 15 lice harvested daily for 1 week and twice a week after
that until no lice from the first generation remained, and, when
present, eggs, larvae, and feces. Blood samples drawn from the
infected rabbit (R1) were positive for B. quintana by culture
and PCR on days 1 and 2, with 2 ⫻ 104/ml and 7 ⫻ 102
CFU/ml, respectively, but were negative on day 3 and at all
later times. On follow-up, the rabbit did not present with any
abnormal symptoms but developed an anti-B. quintana immunoglobulin G response by day 15, with a titer of 1:400 as
determined by indirect immunofluorescence. Blood drawn
from rabbit R2 was negative by both culture and PCR, and
they did not seroconvert. GFP-expressing B. quintana was
grown and PCR amplified from all groups of lice. Between 7
and 20 CFU of Bartonella (mean ⫾ standard deviation ⫽
16.3 ⫾ 2.9) was obtained from each louse (Fig. 1b). The number of CFU did not decrease over time. B. quintana was also
grown and PCR amplified from fecal samples harvested
throughout the experiment. Qualitative but not quantitative
analysis of the colonies grown from infected feces was performed. Only fluorescent colonies grew. The GFP marker was
therefore very useful for directly identifying B. quintana colonies (Fig. 1B). None of the uninfected control lice were positive by culture or PCR analysis. The average daily number of
eggs from the infected group was 682.8 ⫾ 335.1 and was not
significantly different from the 705.2 ⫾ 357.9 observed in the
control group (P ⫽ 0.51). No growth or PCR amplification of
B. quintana was obtained from the 300 eggs and 100 larvae
tested. Unfortunately, we observed that body lice were
autofluorescent, and therefore detection of GFP-expressing
Bartonella was not possible (Fig. 1c).
For histological examination, five lice collected on each of
days 0, 3, 5, 7, and then once a week were fixed in 10% formalin
overnight, paraffin embedded, and cut to 5-m thickness. Hematoxylin-eosin stain was used to visualize the gut system, and

Warthin-Starry stain was used to detect bartonellae. Immunochemistry using anti-B. quintana polyclonal antibodies (11) was
performed on 5-m-thick formalin-fixed and paraffin-embedded gut sections. For each section, a negative control was
prepared using gut sections from uninfected lice. The gut system was easy to recognize by its thin wall and large lumen.
Bartonella were identified as dense clusters of bacteria in the
intestinal lumen. Masses of bacteria occupied an extracellular
location (Fig. 1d).
To determine whether B. quintana would influence louse
mortality, 200 infected lice, half of which were female, were fed
daily on rabbit R2 and were compared with 200 control lice,
half of which were female, that fed only on an SPF rabbit (R3).
The number of dead lice in both groups was compared using a
Kaplan-Meier life table (GB-STAT version 6.5; Dynamic Systems Inc., Silver Springs, Md.), and the equality of survival
between the two populations was estimated using the generalized Wilcoxon test. No significant difference in the mortality
rate was observed between infected and control lice (P ⫽ 0.49)
(Fig. 2).
In conclusion, we report the first experimental animal model
of body louse infection by using a laboratory colony of lice
feeding on a rabbit with a GFP-expressing B. quintana bacteremia. The lice maintained an asymptomatic extracellular infection inside their gut during their entire life but did not
transmit B. quintana to the next generation, supporting the role
of body lice as vectors, but not reservoirs, for B. quintana. This
rabbit model of human body louse infection may be valuable
for other louse-transmitted pathogens.
We thank James M. Battisti, Michael Kovacs, and Raphael Valdivia
for kindly providing plasmids.
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FIG. 2. Comparison of the survival rate over time of 200 lice infected with B. quintana and 200 control lice. Day 0, day of infection.
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